Museo del Oro, Banco de la República. "Museo del Oro, Colombia" (in Spanish). Banrep.gov.co. Archived from the original on 11 May 2013. Retrieved 9 November 2012.
Santos, R. G.; Landeira-Fernandez, J.; Strassman, R. J.; Motta, V.; Cruz, A. P. M. (2007). "Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members". Journal of Ethnopharmacology. 112 (3): 507–513. doi:10.1016/j.jep.2007.04.012. PMID17532158.
de Rios, Marlene Dobkin; Grob, Charles S. (2005). "Interview with Jeffrey Bronfman, Representative Mestre for the União do Vegetal Church in the United States". Journal of Psychoactive Drugs. 37 (2): 181–191. doi:10.1080/02791072.2005.10399800. PMID16149332. S2CID208178224.
Touw, Mia (January 1981). "The Religious and Medicinal Uses of Cannabis in China, India and Tibet". Journal of Psychoactive Drugs. 13 (1): 23–34. doi:10.1080/02791072.1981.10471447. PMID7024492.
Hajicek-Dobberstein (1995). "Soma siddhas and alchemical enlightenment: psychedelic mushrooms in Buddhist tradition". American Journal of Ethnopharmacology. 48 (2): 99–118. doi:10.1016/0378-8741(95)01292-L. PMID8583800.
Stolaroff, M. J. (1999). "Are Psychedelics Useful in the Practice of Buddhism?". Journal of Humanistic Psychology. 39 (1): 60–80. doi:10.1177/0022167899391009. S2CID145220039.
R. R. Griffiths; W. A. Richards; U. McCann; R. Jesse (7 July 2006). "Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance". Psychopharmacology. 187 (3): 268–283. doi:10.1007/s00213-006-0457-5. PMID16826400. S2CID7845214.
Nutt, David J.; King, Leslie A.; Nichols, David E. (2013). "Effects of Schedule I Drug Laws on Neuroscience Research and Treatment Innovation". Nature Reviews Neuroscience. 14 (8): 577–85. doi:10.1038/nrn3530. PMID23756634. S2CID1956833.
Tupper, Kenneth W.; Labate, Beatriz C. (2014). "Ayahuasca, Psychedelic Studies and Health Sciences: The Politics of Knowledge and Inquiry into an Amazonian Plant Brew". Current Drug Abuse Reviews. 7 (2): 71–80. doi:10.2174/1874473708666150107155042. PMID25563448.
Calabrese, Joseph D. (1997). "Spiritual healing and human development in the Native American church: Toward a cultural psychiatry of peyote". Psychoanalytic Review. 84 (2): 237–255. PMID9211587.
Santos, R. G.; Landeira-Fernandez, J.; Strassman, R. J.; Motta, V.; Cruz, A. P. M. (2007). "Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members". Journal of Ethnopharmacology. 112 (3): 507–513. doi:10.1016/j.jep.2007.04.012. PMID17532158.
de Rios, Marlene Dobkin; Grob, Charles S. (2005). "Interview with Jeffrey Bronfman, Representative Mestre for the União do Vegetal Church in the United States". Journal of Psychoactive Drugs. 37 (2): 181–191. doi:10.1080/02791072.2005.10399800. PMID16149332. S2CID208178224.
Touw, Mia (January 1981). "The Religious and Medicinal Uses of Cannabis in China, India and Tibet". Journal of Psychoactive Drugs. 13 (1): 23–34. doi:10.1080/02791072.1981.10471447. PMID7024492.
Hajicek-Dobberstein (1995). "Soma siddhas and alchemical enlightenment: psychedelic mushrooms in Buddhist tradition". American Journal of Ethnopharmacology. 48 (2): 99–118. doi:10.1016/0378-8741(95)01292-L. PMID8583800.
R. R. Griffiths; W. A. Richards; U. McCann; R. Jesse (7 July 2006). "Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance". Psychopharmacology. 187 (3): 268–283. doi:10.1007/s00213-006-0457-5. PMID16826400. S2CID7845214.
Nutt, David J.; King, Leslie A.; Nichols, David E. (2013). "Effects of Schedule I Drug Laws on Neuroscience Research and Treatment Innovation". Nature Reviews Neuroscience. 14 (8): 577–85. doi:10.1038/nrn3530. PMID23756634. S2CID1956833.
Tupper, Kenneth W.; Labate, Beatriz C. (2014). "Ayahuasca, Psychedelic Studies and Health Sciences: The Politics of Knowledge and Inquiry into an Amazonian Plant Brew". Current Drug Abuse Reviews. 7 (2): 71–80. doi:10.2174/1874473708666150107155042. PMID25563448.
de Rios, Marlene Dobkin; Grob, Charles S. (2005). "Interview with Jeffrey Bronfman, Representative Mestre for the União do Vegetal Church in the United States". Journal of Psychoactive Drugs. 37 (2): 181–191. doi:10.1080/02791072.2005.10399800. PMID16149332. S2CID208178224.
Stolaroff, M. J. (1999). "Are Psychedelics Useful in the Practice of Buddhism?". Journal of Humanistic Psychology. 39 (1): 60–80. doi:10.1177/0022167899391009. S2CID145220039.
R. R. Griffiths; W. A. Richards; U. McCann; R. Jesse (7 July 2006). "Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance". Psychopharmacology. 187 (3): 268–283. doi:10.1007/s00213-006-0457-5. PMID16826400. S2CID7845214.
Nutt, David J.; King, Leslie A.; Nichols, David E. (2013). "Effects of Schedule I Drug Laws on Neuroscience Research and Treatment Innovation". Nature Reviews Neuroscience. 14 (8): 577–85. doi:10.1038/nrn3530. PMID23756634. S2CID1956833.
Museo del Oro, Banco de la República. "Museo del Oro, Colombia" (in Spanish). Banrep.gov.co. Archived from the original on 11 May 2013. Retrieved 9 November 2012.
Mayor, Adrienne (2014). The Amazons : lives and legends of warrior women across the ancient world. Princeton. pp. 147–149. ISBN9780691147208. OCLC882553191.{{cite book}}: CS1 maint: location missing publisher (link)
Roth, Cecil. (1972). Encyclopedia Judaica. 1st Ed. Volume 8. p. 323. OCLC830136076. Note, the second edition of the Encyclopedia Judaica no longer mentions Sula Benet but continues to maintain that hemp is "the plant Cannabis sativa called kanbus in talmudic literature", but now adds, "Hashish is not mentioned however in Jewish sources". See p. 805 in Vol. 8 of the 2nd edition.